Skip to content
btc Bitcoin $70,702 0.18% eth Ethereum $2,153 0.62% usdt Tether $1 -0.01% xrp XRP $1 -0.44% bnb BNB $642 -0.11% usdc USDC $1 0.00% sol Solana $90 0.69% trx TRON $0 1.92% figr_heloc Figure Heloc $1 2.72% doge Dogecoin $0 -0.21%

Biotech firm 180 Life Sciences to rebrand as ETHZilla and build an ethereum treasury

New Ether Treasury Firm 'ETHZilla' Emerges With $425M Funding and a DeFi Twist
SHARE THIS ARTICLE

Nasdaq‑listed 180 Life Sciences, which goes with the ticker name ATNF, announced that it has secured a $425 million private investment in public equity (PIPE) to build an Ether‑focused treasury strategy. The company is expected to rebrand as ETHZilla Corporation and adopt ETH as its principal treasury asset, the company said in a press release. The PIPE transaction is expected to close on or around August 1, 2025, subject to the satisfaction of customary closing conditions.

A $425 million funding round

The PIPE round involved more than 60 institutional and crypto-native backers, including Polychain Capital, Electric Capital, and GSR. Founders of DeFi protocols like Lido, EigenLayer, and Compound also participated in the funding. ETHZilla will work with DeFi experts to earn returns on its ETH through staking, lending, and other on-chain methods. A newly formed “DeFi Council” and a partnership with Etherealize are set to guide ETHZilla’s on-chain yield strategy.

ETHZilla intends to employ Electric Capital as its external manager to architect a differentiated yield generation program. The strategy is designed to generate operating return from ETH reserves while maintaining risk controls through diversified deployment.

Corporate ETH treasury strategies gain traction

ETHZilla joins the growing wave of public companies adopting Ethereum-centric treasury policies. Some of these companies include SharpLink Gaming, BitMine, and Bit Digital. Bernstein recently reported that firms are shifting from Bitcoin-only reserves to ETH staking models, targeting yield just under 3%, generating potentially $30–50 million per billion USD of ETH held. Standard Chartered estimates these corporate ETH treasuries collectively now control over $9 million worth or about 2% of the total ETH supply.

Biotech firm 180 Life Sciences to rebrand as ETHZilla and build an ethereum treasury

Ether is currently trading at ~$3,820, after touching a six-month high near $3,876. Over recent weeks, ETH-linked equities, especially those managing ETH treasuries, have rallied in part due to strong institutional interest and recent U.S. legislation on stablecoins. Ethereum ETFs have also surged, up around 36% month‑to‑date, far outperforming Bitcoin ETFs in the same period.

Biotech firm 180 Life Sciences to rebrand as ETHZilla and build an ethereum treasury

Coin Headlines covers the latest news in crypto, blockchain, Web3, and markets, bringing you credible and up-to-date information on all the latest developments from around the world.

We focus on real-time news updates, market movements, whale transfers, and macroeconomic trends to keep you informed and engaged. Whether it’s Bitcoin price swings, altcoin updates, meme coin hype, regulatory changes, or major moves from the world of traditional finance, Coin Headlines gives you what you need to know, right when you need it.